Merck Tbk
Hub Segmentasi: Analisis Fundamental Umum (General Hub)
Tingkat pengembalian modal yang diinvestasikan. Nilai > 12% menunjukkan alokasi modal...
Mendeteksi kualitas laba bersih. Rasio di luar rentang -10% s/d 10% mengindikasikan l...
Rasio total utang terhadap modal ekuitas bersih.
Diagnosis Kesimpulan Sektor
Kinerja fundamental stabil, namun perhatikan tingkat margin laba bersih operasional dan rasio utang ekuitas.
Emiten teratas dalam sektor Healthcare
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.
Beginner Insight:Understanding the "Architecture" helps you verify the company's physical scale and legitimacy. A global workforce usually indicates a mature, institutional player.